Clinical Updates

Drug approvals, guideline changes, and treatment advances

Engineered Islet Transplant Survives Without Immunosuppression in First-in-Human Trial

A first-in-human trial published in the New England Journal of Medicine demonstrates long-term survival of genetically engineered pancreatic islet cells…

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

More form Clinical Updates

BioNTech-Pfizer Bispecific Antibody Shows Promise in Advanced Lung Cancer at ASCO 2026

BioNTech and Pfizer's experimental bispecific antibody BNT327 showed promising activity in advanced lung cancer patients…

Medically Tailored Meals Reduce Healthcare Costs by $2,400 Per Person, US Analysis Shows

New analysis shows medically tailored meal programs reduce healthcare costs by $2,400 per person annually.…

New Drug Daraxonrasib Nearly Doubles Pancreatic Cancer Survival in Phase 3 Trial

Daraxonrasib nearly doubles survival in advanced pancreatic cancer patients with KRAS G12C mutations. The breakthrough…

Mobile NHS lung cancer screening detects 10,000 cases in supermarket car parks

NHS mobile lung cancer screening units operating in supermarket car parks have successfully detected 10,000…

Immune Drug Delays Rheumatoid Arthritis by Four Years After Treatment Ends

Clinical trial shows one year of abatacept treatment delayed rheumatoid arthritis onset by up to…